Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 EUR | 0.00% | +3.40% | -22.12% |
Apr. 23 | Maps, to group company project from Novara Health Authority | AN |
Mar. 28 | Futures tentatively up, eyes on macros | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 28.59 | 21.88 | 37.89 | 41.77 | 38.64 | 30.1 | - | - |
Enterprise Value (EV) 1 | 32.99 | 28.89 | 38.98 | 56.65 | 38.64 | 39.25 | 36.15 | 32.25 |
P/E ratio | - | - | - | - | - | 13.1 x | 9.35 x | 7.71 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.68 x | 1.22 x | 1.57 x | 1.69 x | 1.4 x | 0.99 x | 0.9 x | 0.82 x |
EV / Revenue | 1.94 x | 1.61 x | 1.61 x | 2.29 x | 1.4 x | 1.3 x | 1.08 x | 0.88 x |
EV / EBITDA | 8.71 x | 8.49 x | 8.11 x | 9.62 x | 7.76 x | 5.86 x | 4.55 x | 3.6 x |
EV / FCF | 58.1 x | -38.7 x | 12.3 x | -9.05 x | 33.7 x | 18.3 x | 10.8 x | 7.87 x |
FCF Yield | 1.72% | -2.59% | 8.16% | -11% | 2.97% | 5.48% | 9.27% | 12.7% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 9,133 | 9,640 | 9,640 | 11,668 | 12,386 | 12,386 | - | - |
Reference price 2 | 3.130 | 2.270 | 3.930 | 3.580 | 3.120 | 2.430 | 2.430 | 2.430 |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 17.03 | 17.93 | 24.14 | 24.75 | 27.55 | 30.3 | 33.35 | 36.65 |
EBITDA 1 | 3.788 | 3.405 | 4.804 | 5.887 | 4.977 | 6.7 | 7.95 | 8.95 |
EBIT 1 | 2.042 | 1.132 | 2.21 | 3.095 | 4.977 | 3.2 | 4.3 | 5.2 |
Operating Margin | 11.99% | 6.31% | 9.15% | 12.51% | 18.07% | 10.56% | 12.89% | 14.19% |
Earnings before Tax (EBT) 1 | - | - | - | - | - | 2.5 | 3.7 | 4.6 |
Net income 1 | - | - | 2.515 | 2.695 | 0.9246 | 2.35 | 3.25 | 3.9 |
Net margin | - | - | 10.42% | 10.89% | 3.36% | 7.76% | 9.75% | 10.64% |
EPS 2 | - | - | - | - | - | 0.1850 | 0.2600 | 0.3150 |
Free Cash Flow 1 | 0.5679 | -0.7471 | 3.179 | -6.258 | 1.147 | 2.15 | 3.35 | 4.1 |
FCF margin | 3.33% | -4.17% | 13.17% | -25.28% | 4.16% | 7.1% | 10.04% | 11.19% |
FCF Conversion (EBITDA) | 14.99% | - | 66.18% | - | 23.04% | 32.09% | 42.14% | 45.81% |
FCF Conversion (Net income) | - | - | 126.41% | - | 124.01% | 91.49% | 103.08% | 105.13% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 4.4 | 7.01 | 1.09 | 14.9 | - | 9.15 | 6.05 | 2.15 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.162 x | 2.058 x | 0.2275 x | 2.527 x | - | 1.366 x | 0.761 x | 0.2402 x |
Free Cash Flow 1 | 0.57 | -0.75 | 3.18 | -6.26 | 1.15 | 2.15 | 3.35 | 4.1 |
ROE (net income / shareholders' equity) | 28.6% | 9.98% | 17% | 15% | - | 8.9% | 11% | 11.7% |
ROA (Net income/ Total Assets) | - | - | 3.39% | 5.43% | - | 5.8% | 7.8% | 9.3% |
Assets 1 | - | - | 74.19 | 49.61 | - | 40.52 | 41.67 | 41.94 |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 2.52 | 5.14 | 5.6 | 7.78 | 4.43 | 2.75 | 2.75 | 2.8 |
Capex / Sales | 14.81% | 28.67% | 23.2% | 31.42% | 16.08% | 9.08% | 8.25% | 7.64% |
Announcement Date | 3/27/20 | 3/26/21 | 4/11/22 | 3/24/23 | 3/27/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.12% | 32.13M | |
-12.23% | 194B | |
+0.74% | 166B | |
+2.19% | 153B | |
+4.34% | 99.85B | |
+7.04% | 77.56B | |
+19.09% | 73.55B | |
-7.30% | 71B | |
-20.54% | 52.81B | |
+0.53% | 47.86B |
- Stock Market
- Equities
- MAPS Stock
- Financials Maps S.p.A.